Výsledky vyhledávání

Clinical features and outcomes in chronic myeloid leukemia with T315I mutation

Autor: Julia Yu. Vlasova, Maria V. Barabanshchikova, Irina Martynkevich, Boris V. Afanasyev, Vasily Shuvaev, I. Barhatov, Anna G. Turkina, Tatiana Gindina, Elena V. Morozova, Oleg Shukhov

Publikováno v: Cellular Therapy and Transplantation. 6:26-35

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5abd95f64430be2dedf6605faba789e0
https://doi.org/10.18620/ctt-1866-8836-2017-6-2-26-35

Zobrazit plný text záznamu

The Outcome of Patients with Advanced Phase Chronic Myeloid Leukemia with and without Allogeneic Hemopoietic Stem Cell Transplantation

Autor: Ivan S. Moiseev, Julia J. Vlasova, Axel R. Zander, I. Barhatov, Elena V. Morozova, TL Gindina, Ludmila S. Zubarovskaya, Sergey N. Bondarenko, Maria V. Barabanshikova, Aleksandr D. Kulagin, Ksenia Jurovskaya

Publikováno v: Blood. 136:29-30

Introduction: In spite of the widespread use of second- and third-generation tyrosine kinase inhibitors (TKIs) the prognosis of patients with advanced phase CML (accelerated phase (AP) or blast crisis (BC)) is still dismal. The aim of this study was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2bb0146d36d2d7636a798cd1088fb7f2
https://doi.org/10.1182/blood-2020-139452

Zobrazit plný text záznamu

A Prospective Pilot Study of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis

Autor: I. Barhatov, Elena I. Darskaya, Tatjana Alexandrovna Rudakova, Maria V. Barabanshikova, Gennadij Georgievich Rodionov, Boris V. Afanasyev, V. Baykov, Ivan S. Moiseev, Elena Surkova, Sergey N. Bondarenko, Sergey Ivanovich Moiseev, Elena V. Morozova, Alena I. Shakirova, Alksandr Leonidovich Alyanski, Sergey V. Lapin, Julia J. Vlasova, Inna Edvardovna Ushal

Publikováno v: Acta haematologica. 144(2)

Introduction: This prospective study evaluated a calcineurin inhibitor-free graft-versus-host disease (GVHD) prophylaxis regimen of ruxolitinib in combination with post-transplant cyclophosphamide (PTCy). Patents and Methods: Twenty patients with pri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eba83f1b1cfeab44b9d55bd91d3e8fb6
https://pubmed.ncbi.nlm.nih.gov/32814312

Zobrazit plný text záznamu

Usage of Indicators of the Small Business Taxation in USA and Modern Russia

Autor: E. V. Shestakova, Y. S. Kapkaev, S. V. Kaledin, V. I. Barhatov

Publikováno v: Proceedings of the International Scientific Conference "Far East Con" (ISCFEC 2018).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8c2ee339f08ccbbda5ee5d032da9631e
https://doi.org/10.2991/iscfec-18.2019.72

Zobrazit plný text záznamu

Influence of nivolumab on epidemiology of infectious complications in patients with relapse or refractory Hodgkin’s lymphoma

Autor: Y. Rogacheva, I. Barhatov, Ivan S. Moiseev, V. Baykov, A. Volkova, Y. Zalyalov, Kirill V. Lepik, Boris V. Afanasyev, N. Mikhailova, Nikolay Klimko, E. Kondakova, Sergey N. Bondarenko, M. Popova, I. Nikolaev, O. Goloshchapov, L. Stelmah

Publikováno v: Annals of Oncology. 30:xi23

Background The clinical development of checkpoint inhibitor-based immunotherapy has ushered in an exciting era of anticancer therapy. Despite many reports on anti PD-1 antibody therapy for the treatment of Hodgkin’s lymphoma (HL), the risk of infec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::118045a7aa448b563594b38c67a55980
https://doi.org/10.1093/annonc/mdz449.017

Zobrazit plný text záznamu

Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) with Different Intensity Conditioning Regimens in Children with Very High Risk Acute Lymphoblastic Leukemia (VHR ALL): A Single-Center Experience

Autor: Ludmila S. Zubarovskaya, I. Barhatov, Tatiana A Bykova, Sergey N. Bondarenko, Kirill Alexandrovich Ekushov, Axel R. Zander, E.V. Semenova, Anna A. Osipova, Olesia V Paina, P.V. Kozhokar, Zhemal Zarifovna Rakhmanova, Elena V. Babenko, Ivan S. Moiseev, Anastasia S Frolova, Boris V. Afanasyev, Inna V. Markova, Aleksandr Alyanski

Publikováno v: Blood. 134:2050-2050

Background: Allo-HSCT with myeloablative conditioning (MAC) has traditionally been performed in patients with ALL and has been associated with significant transplant-related morbidity and mortality. Reduced-intensity conditioning (RIC) is used in pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::43adfcee10f5330699d7325bda57f71f
https://doi.org/10.1182/blood-2019-128163

Zobrazit plný text záznamu

INFECTIOUS COMPLICATIONS OF NIVOLUMAB THERAPY IN RELAPSED/REFRACTORY HODGKIN'S LYMPHOMA

Autor: E. Kondakova, M. Popova, Kirill V. Lepik, N. Mikhailova, O. Goloshchapov, Y. Rogacheva, Ivan S. Moiseev, Y. Zalyalov, V. Baykov, Sergey N. Bondarenko, I. Nikolaev, Nikolay Klimko, I. Barhatov, Boris V. Afanasyev, A. Volkova, L. Stelmah

Publikováno v: Hematological Oncology. 37:502-502

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dbfef131c9f814b1c6a3b1513fbc3511
https://doi.org/10.1002/hon.184_2631

Zobrazit plný text záznamu

PS1282 INFECTIOUS COMPLICATIONS OF NIVOLUMAB THERAPY IN RELAPSED/REFRACTORY HODGKIN'S LYMPHOMA

Autor: I. Barhatov, Sergey N. Bondarenko, M. Popova, A. Volkova, L. Stelmakh, E. Kondakova, N. Mikhailova, V. Baykov, O. Goloshchapov, Nikolay Klimko, Boris V. Afanasyev, Y. Zalyalov, I. Nikolaev, Ivan S. Moiseev, Kirill V. Lepik, Y. Rogacheva

Publikováno v: HemaSphere. 3:587

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2893f56d113e7a19c776c62a2c315537
https://doi.org/10.1097/01.hs9.0000563408.35830.4c

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání